title: Disentangling the role of the tau gene locus in sporadic tauopathies.
abstract: Fibrillar aggregates of abnormally hyperphosphorylated tau protein are the major component of the pathological entities, including intraneuronal neurofibrillary tangles that define the broad class of late-onset neurodegenerative disorders called the tauopathies. Mutations in the tau gene (MAPT) causing familial frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) confirm that tau protein dysfunction could be a primary cause of neuronal loss. However, in the sporadic tauopathies such as progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) where MAPT mutation is absent, common variation in MAPT that defines the H1 and H2 haplotype clades strongly influences disease risk. Surprisingly, this influence on risk extends to sporadic Parkinson's disease (PD), traditionally not defined as a tauopathy. This review will focus on recent work aimed at elucidating the mechanistic basis of this haplotype-specific effect on disease risk, implicating elevated levels of MAPT expression, particularly via increased transcription and/or alterations in splicing. This conforms to an emerging picture of a shared mechanism that underlies the fundamental process(es) leading to neuronal death. Increased availability of the fibrillogenic protein substrates of the pathological aggregates that define several neurodegenerative proteopathies, eg α-synuclein in PD, β-amyloid in AD and tau in the tauopathies, contributes to causation and risk in the familial and sporadic forms of these disorders, respectively.
authors: Reta Lila Weston Institute & Department of Molecular Neuroscience, UCL Institute of Neurology, 1 Wakefield Street, London, WC1N 1PJ, UK.
authors: J
authors: J
authors: Vandrovcova
authors: F
authors: F
authors: Anaya
authors: V
authors: V
authors: Kay
authors: A
authors: A
authors: Lees
authors: J
authors: J
authors: Hardy
authors: R
authors: R
authors: de Silva
mesh_terms: D000818:Animals; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D009410:Nerve Degeneration / Q000175:diagnosis* / Q000235:genetics* / Q000378:metabolism; D024801:Tauopathies / Q000175:diagnosis* / Q000235:genetics* / Q000378:metabolism; D016875:tau Proteins / Q000235:genetics*
chemical_list: D005819:Genetic Markers; C054369:MAPT protein, human; D016875:tau Proteins